668 related articles for article (PubMed ID: 17380490)
41. Complement regulatory proteins are incorporated into lentiviral vectors and protect particles against complement inactivation.
Schauber-Plewa C; Simmons A; Tuerk MJ; Pacheco CD; Veres G
Gene Ther; 2005 Feb; 12(3):238-45. PubMed ID: 15550926
[TBL] [Abstract][Full Text] [Related]
42. [High efficiency gene transfer into breast cancer cells by pseudotyped retroviral vector].
Tang LL; Yu H
Hunan Yi Ke Da Xue Xue Bao; 2001 Feb; 26(1):48-50. PubMed ID: 12536615
[TBL] [Abstract][Full Text] [Related]
43. Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors.
Rahim AA; Wong AM; Howe SJ; Buckley SM; Acosta-Saltos AD; Elston KE; Ward NJ; Philpott NJ; Cooper JD; Anderson PN; Waddington SN; Thrasher AJ; Raivich G
Gene Ther; 2009 Apr; 16(4):509-20. PubMed ID: 19158847
[TBL] [Abstract][Full Text] [Related]
44. Shuttle of lentiviral vectors via transplanted cells in vivo.
Blömer U; Gruh I; Witschel H; Haverich A; Martin U
Gene Ther; 2005 Jan; 12(1):67-74. PubMed ID: 15385952
[TBL] [Abstract][Full Text] [Related]
45. Preparation and quantification of pseudotyped retroviral vector.
Yu H; Kwon YJ
Methods Mol Biol; 2008; 433():1-16. PubMed ID: 18679614
[TBL] [Abstract][Full Text] [Related]
46. Superior transduction of mouse hematopoietic stem cells with 10A1 and VSV-G pseudotyped retrovirus vectors.
Barrette S; Douglas J; Orlic D; Anderson SM; Seidel NE; Miller AD; Bodine DM
Mol Ther; 2000 Apr; 1(4):330-8. PubMed ID: 10933951
[TBL] [Abstract][Full Text] [Related]
47. Systematic improvement of lentivirus transduction protocols by antibody fragments fused to VSV-G as envelope glycoprotein.
Höfig I; Barth S; Salomon M; Jagusch V; Atkinson MJ; Anastasov N; Thirion C
Biomaterials; 2014 Apr; 35(13):4204-12. PubMed ID: 24529898
[TBL] [Abstract][Full Text] [Related]
48. Single-dose lentiviral gene transfer for lifetime airway gene expression.
Stocker AG; Kremer KL; Koldej R; Miller DS; Anson DS; Parsons DW
J Gene Med; 2009 Oct; 11(10):861-7. PubMed ID: 19634193
[TBL] [Abstract][Full Text] [Related]
49. Transduction of human islets with pseudotyped lentiviral vectors.
Kobinger GP; Deng S; Louboutin JP; Vatamaniuk M; Matschinsky F; Markmann JF; Raper SE; Wilson JM
Hum Gene Ther; 2004 Feb; 15(2):211-9. PubMed ID: 14975193
[TBL] [Abstract][Full Text] [Related]
50. Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins.
Desmaris N; Bosch A; Salaün C; Petit C; Prévost MC; Tordo N; Perrin P; Schwartz O; de Rocquigny H; Heard JM
Mol Ther; 2001 Aug; 4(2):149-56. PubMed ID: 11482987
[TBL] [Abstract][Full Text] [Related]
51. Exposure of lentiviral vectors to subneutral pH shifts the tropism from Purkinje cell to Bergmann glia.
Torashima T; Yamada N; Itoh M; Yamamoto A; Hirai H
Eur J Neurosci; 2006 Jul; 24(2):371-80. PubMed ID: 16836635
[TBL] [Abstract][Full Text] [Related]
52. Lentivirus-mediated gene transfer of gp91phox corrects chronic granulomatous disease (CGD) phenotype in human X-CGD cells.
Saulnier SO; Steinhoff D; Dinauer MC; Zufferey R; Trono D; Seger RA; Hossle JP
J Gene Med; 2000; 2(5):317-25. PubMed ID: 11045425
[TBL] [Abstract][Full Text] [Related]
53. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
[TBL] [Abstract][Full Text] [Related]
54. Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research.
Schambach A; Galla M; Modlich U; Will E; Chandra S; Reeves L; Colbert M; Williams DA; von Kalle C; Baum C
Exp Hematol; 2006 May; 34(5):588-92. PubMed ID: 16647564
[TBL] [Abstract][Full Text] [Related]
55. Late generation lentiviral vectors: evaluation of inflammatory potential in human airway epithelial cells.
Copreni E; Nicolis E; Tamanini A; Bezzerri V; Castellani S; Palmieri L; Giri MG; Vella A; Colombatti M; Rizzotti P; Conese M; Cabrini G
Virus Res; 2009 Sep; 144(1-2):8-17. PubMed ID: 19447514
[TBL] [Abstract][Full Text] [Related]
56. A stable system for the high-titer production of multiply attenuated lentiviral vectors.
Klages N; Zufferey R; Trono D
Mol Ther; 2000 Aug; 2(2):170-6. PubMed ID: 10947945
[TBL] [Abstract][Full Text] [Related]
57. The Effects of Conditioning and Lentiviral Vector Pseudotype on Short- and Long-Term Airway Reporter Gene Expression in Mice.
Carpentieri C; Farrow N; Cmielewski P; Rout-Pitt N; McCarron A; Knight E; Parsons D; Donnelley M
Hum Gene Ther; 2021 Aug; 32(15-16):817-827. PubMed ID: 33947249
[TBL] [Abstract][Full Text] [Related]
58. Transduction of ferret airway epithelia using a pre-treatment and lentiviral gene vector.
Cmielewski P; Farrow N; Donnelley M; McIntyre C; Penny-Dimri J; Kuchel T; Parsons D
BMC Pulm Med; 2014 Nov; 14():183. PubMed ID: 25413892
[TBL] [Abstract][Full Text] [Related]
59. Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model.
Kyriakou CA; Yong KL; Benjamin R; Pizzey A; Dogan A; Singh N; Davidoff AM; Nathwani AC
J Gene Med; 2006 Mar; 8(3):253-64. PubMed ID: 16288493
[TBL] [Abstract][Full Text] [Related]
60. Gene therapy for Cystic Fibrosis: Improved delivery techniques and conditioning with lysophosphatidylcholine enhance lentiviral gene transfer in mouse lung airways.
Cmielewski P; Farrow N; Devereux S; Parsons D; Donnelley M
Exp Lung Res; 2017; 43(9-10):426-433. PubMed ID: 29236544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
